{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:39:12Z","timestamp":1792694352305,"version":"4.5.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":257,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shanghai Oriental Talent Award","award":["QNWS2024045"],"award-info":[{"award-number":["QNWS2024045"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171644"],"award-info":[{"award-number":["82171644"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Shen Kang Hospital Development Center Municipal Hospital New Frontier Technology Joint Project","award":["SHDC12017105"],"award-info":[{"award-number":["SHDC12017105"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>STUDY QUESTION<\/jats:title>\n                    <jats:p>In patients undergoing preimplantation genetic testing for aneuploidy (PGT-A), does the progestin-primed ovarian stimulation (PPOS) protocol result in a euploidy rate of blastocysts per patient comparable to that of the GnRH antagonist protocol?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY ANSWER<\/jats:title>\n                    <jats:p>The euploidy rate of blastocysts per patient is comparable for patients using PPOS and GnRH antagonist protocols.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                    <jats:p>Progestin is effective in blocking the pituitary LH surge during ovarian stimulation, and the PPOS protocol is simpler and cheaper. However, published studies comparing euploidy rates between the two protocols have yielded contradictory results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                    <jats:p>This was an open-label, randomized controlled trial of 400 women recruited between June 2020 and August 2024. Eligible women were randomly assigned in a ratio of 1:1 to the PPOS or GnRH antagonist group using an online randomization programme and sealed opaque envelopes. The primary outcome was the euploidy rate of blastocysts per patient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                    <jats:p>Women aged &amp;lt;43\u2009years undergoing PGT-A cycles were randomly assigned to either the PPOS group (n\u2009=\u2009200) or antagonist group (n\u2009=\u2009200). PGT-A was indicated for advanced maternal age, recurrent pregnancy loss, repeated implantation failure, or history of foetal aneuploidy in previous pregnancies. PGT-A was performed using the next-generation sequencing technology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                    <jats:p>The PPOS and antagonist groups were similar in demographic characteristics and the numbers of oocytes obtained\/fertilized, cleavage-stage embryos, and developed blastocysts. The PPOS group had a significantly lower total gonadotrophin doses and significantly higher serum oestradiol levels on the ovulation trigger day when compared to the GnRH antagonist group. No statistically significant difference was observed in the euploidy rate of blastocysts between the PPOS and antagonist groups (40.0 (0\u201366.7)% versus 44.4 (25.0\u201371.4)%, P\u2009=\u20090.192). The number of euploid blastocysts per patient was comparable for the PPOS and antagonist groups (1 (1\u20132) versus 1 (1\u20132.5), P\u2009=\u20090.47). There were 136 women in the PPOS group and 152 women in the antagonist group who had their first frozen embryo transfer after PGT-A. Both groups showed comparable clinical pregnancy, ongoing pregnancy, miscarriage, ectopic pregnancy, and live birth rates after the first frozen embryo transfer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                    <jats:p>The participants and researchers were not blinded to the treatment allocation. The sample size was powered only to detect a 10% euploidy rate difference; smaller differences cannot be excluded. Not all women completed their first transfer cycle, and outcomes from a single cycle do not represent cumulative live birth rates. Results are based solely on euploid embryo transfers, limiting generalizability to mosaic embryos. Generalization to other IVF populations or to the use of other progestins is also limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WIDER IMPLICATION OF THE FINDINGS<\/jats:title>\n                    <jats:p>The findings of the study support the use of PPOS for patients undergoing a freeze-all IVF cycle, whether for PGT-A or oocyte preservation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>FUNDING<\/jats:title>\n                    <jats:p>This study was supported by Shanghai Oriental Talent Award (QNWS2024045), the National Natural Science Foundation of China (82171644), and Shanghai Shen Kang Hospital Development Center Municipal Hospital New Frontier Technology Joint Project (SHDC12017105).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCLOSURES<\/jats:title>\n                    <jats:p>The authors report no conflicts of interest.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                    <jats:p>NCT04414748.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION DATE<\/jats:title>\n                    <jats:p>4 June 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATE OF FIRST PATIENT\u2019S ENROLLMENT<\/jats:title>\n                    <jats:p>10 June 2020.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/hropen\/hoag081","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:20:19Z","timestamp":1789384819000},"source":"Crossref","is-referenced-by-count":0,"title":["Comparing the euploidy rate between the progestin-primed and gonadotrophin-releasing hormone antagonist protocols in preimplantation genetic testing for aneuploidy: a randomized controlled trial"],"prefix":"10.1093","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5025-2212","authenticated-orcid":false,"given":"He","family":"Li","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong ,","place":["China"]},{"name":"Shanghai Ji Ai Genetics and IVF Institute, Obstetrics and Gynecology Hospital, Fudan University , Shanghai,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yu","sequence":"additional","affiliation":[{"name":"Shanghai Ji Ai Genetics and IVF Institute, Obstetrics and Gynecology Hospital, Fudan University , Shanghai,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[{"name":"Shanghai Ji Ai Genetics and IVF Institute, Obstetrics and Gynecology Hospital, Fudan University , Shanghai,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Lu","sequence":"additional","affiliation":[{"name":"Shanghai Ji Ai Genetics and IVF Institute, Obstetrics and Gynecology Hospital, Fudan University , Shanghai,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[{"name":"Shanghai Ji Ai Genetics and IVF Institute, Obstetrics and Gynecology Hospital, Fudan University , Shanghai,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7688-4557","authenticated-orcid":false,"given":"Ernest Hung Yu","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3366-5821","authenticated-orcid":false,"given":"Xiaoxi","family":"Sun","sequence":"additional","affiliation":[{"name":"Shanghai Ji Ai Genetics and IVF Institute, Obstetrics and Gynecology Hospital, Fudan University , Shanghai,","place":["China"]},{"name":"Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital, Fudan University , Shanghai,","place":["China"]},{"name":"Obstetrics and Gynecology Hospital, Fudan University , Shanghai,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"2026102213573501900_hoag081-B1","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.rbmo.2020.01.027","article-title":"Progestins versus GnRH analogues for pituitary suppression during ovarian stimulation for assisted reproductive technology: a systematic review and meta-analysis","volume":"40","author":"Alexandru","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"2026102213573501900_hoag081-B2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","article-title":"Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses","volume":"27","author":"Ata","year":"2021","journal-title":"Hum Reprod Update"},{"key":"2026102213573501900_hoag081-B3","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/humrep\/dez034","article-title":"Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial","volume":"34","author":"Beguer\u00eda","year":"2019","journal-title":"Hum Reprod"},{"key":"2026102213573501900_hoag081-B5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00404-020-05939-y","article-title":"Effectiveness of progesterone-primed ovarian stimulation in assisted reproductive technology: a systematic review and meta-analysis","volume":"303","author":"Cui","year":"2021","journal-title":"Arch Gynecol Obstet"},{"key":"2026102213573501900_hoag081-B7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-0378(01)00136-X","article-title":"Physiology and culture of the human blastocyst","volume":"55","author":"Gardner","year":"2002","journal-title":"J Reprod Immunol"},{"key":"2026102213573501900_hoag081-B8","doi-asserted-by":"crossref","first-page":"702558","DOI":"10.3389\/fendo.2021.702558","article-title":"Progestin-primed ovarian stimulation protocol for patients in assisted reproductive technology: a meta-analysis of randomized controlled trials","volume":"12","author":"Guan","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026102213573501900_hoag081-B9","doi-asserted-by":"crossref","first-page":"e0145895","DOI":"10.1371\/journal.pone.0145895","article-title":"Elevated progesterone levels on the day of oocyte maturation may affect top quality embryo IVF cycles","volume":"11","author":"Huang","year":"2016","journal-title":"PLoS One"},{"key":"2026102213573501900_hoag081-B10","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/humrep\/deaa068","article-title":"Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation","volume":"35","author":"La Marca","year":"2020","journal-title":"Hum Reprod"},{"key":"2026102213573501900_hoag081-B11","doi-asserted-by":"crossref","first-page":"e079208","DOI":"10.1136\/bmjopen-2023-079208","article-title":"Comparing blastocyst euploid rates between the progestin-primed and gonadotrophin-releasing hormone antagonist protocols in aneuploidy genetic testing: a randomised trial protocol","volume":"14","author":"Li","year":"2024","journal-title":"BMJ Open"},{"key":"2026102213573501900_hoag081-B12","first-page":"211","article-title":"New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF","volume":"23","author":"Massin","year":"2017","journal-title":"Hum Reprod Update"},{"key":"2026102213573501900_hoag081-B13","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/humrep\/dei474","article-title":"The significance of premature luteinization in an oocyte-donation programme","volume":"21","author":"Melo","year":"2006","journal-title":"Hum Reprod"},{"key":"2026102213573501900_hoag081-B14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12958-023-01124-3","article-title":"Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF","volume":"21","author":"Pai","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"key":"2026102213573501900_hoag081-B15","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s10815-021-02197-y","article-title":"Elevated serum progesterone does not impact euploidy rates in PGT-A patients","volume":"38","author":"Pardi\u00f1as","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"2026102213573501900_hoag081-B8128446","first-page":"577","article-title":"Chinese Expert consensus on genetic counseling and transfer strategies of mosaic embryos in PGT-A","volume":"59","author":"Professional Committee on Reproductive Medicine, Chinese Medical Doctor Association & Chinese Society of Reproduction Medicine, Chinese Medical Association","year":"2024","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"2026102213573501900_hoag081-B16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/humrep\/dez238","article-title":"Do we need to measure progesterone in oocyte donation cycles? A retrospective analysis evaluating cumulative live birth rates and embryo quality","volume":"35","author":"Racca","year":"2020","journal-title":"Hum Reprod"},{"key":"2026102213573501900_hoag081-B17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/humrep\/dey031","article-title":"Impact of late-follicular phase elevated serum progesterone on cumulative live birth rates: is there a deleterious effect on embryo quality?","volume":"33","author":"Racca","year":"2018","journal-title":"Hum Reprod"},{"key":"2026102213573501900_hoag081-B18","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1093\/oxfordjournals.humrep.a135864","article-title":"Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone","volume":"10","author":"Ubaldi","year":"1995","journal-title":"Hum Reprod"},{"key":"2026102213573501900_hoag081-B19","doi-asserted-by":"crossref","first-page":"e0176482","DOI":"10.1371\/journal.pone.0176482","article-title":"Top quality blastocyst formation rates in relation to progesterone levels on the day of oocyte maturation in GnRH antagonist IVF\/ ICSI cycles","volume":"12","author":"Vanni","year":"2017","journal-title":"PLoS One"},{"key":"2026102213573501900_hoag081-B20","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/humrep\/deae047","article-title":"Ovarian response and embryo ploidy following oral micronized progesterone-primed ovarian stimulation versus GnRH antagonist protocol. A prospective study with repeated ovarian stimulation cycles","volume":"39","author":"Vidal","year":"2024","journal-title":"Hum Reprod"},{"key":"2026102213573501900_hoag081-B21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40001-023-01000-1","article-title":"Analysis of euploidy rates in preimplantation genetic testing for aneuploidy cycles with progestin-primed versus GnRH agonist\/antagonist protocol","volume":"28","author":"Wang","year":"2023","journal-title":"Eur J Med Res"},{"key":"2026102213573501900_hoag081-B22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12958-025-01404-0","article-title":"Comparison of the euploidy rate in preimplantation genetic testing for aneuploidy cycles following progestin-primed versus gonadotropin-releasing hormone antagonist protocol: a randomized controlled study","volume":"23","author":"Wang","year":"2025","journal-title":"Reprod Biol Endocrinol"},{"key":"2026102213573501900_hoag081-B23","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jmoldx.2021.02.011","article-title":"Next-generation sequencing is more efficient at detecting mosaic embryos and improving pregnancy outcomes than single-nucleotide polymorphism array analysis","volume":"23","author":"Xiao","year":"2021","journal-title":"J Mol Diagn"},{"key":"2026102213573501900_hoag081-B24","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.fertnstert.2012.03.014","article-title":"Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles","volume":"97","author":"Xu","year":"2012","journal-title":"Fertil Steril"},{"key":"2026102213573501900_hoag081-B25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.rbmo.2022.03.003","article-title":"Euploidy rates among preimplantation genetic testing for aneuploidy cycles with oral dydrogesterone primed ovarian stimulation or GnRH antagonist protocol","volume":"45","author":"Yang","year":"2022","journal-title":"Reprod Biomed Online"},{"key":"2026102213573501900_hoag081-B26","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s10815-020-01755-0","article-title":"Impact of progestin ovarian stimulation on newborn outcomes: a meta-analysis","volume":"37","author":"Zolfaroli","year":"2020","journal-title":"J Assist Reprod Genet"}],"container-title":["Human Reproduction Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/hropen\/advance-article-pdf\/doi\/10.1093\/hropen\/hoag081\/71089405\/hoag081.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hropen\/article-pdf\/2026\/4\/hoag081\/71089405\/hoag081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hropen\/article-pdf\/2026\/4\/hoag081\/71089405\/hoag081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:57:47Z","timestamp":1792691867000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hropen\/article\/doi\/10.1093\/hropen\/hoag081\/8796060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,9,17]]}},"URL":"https:\/\/doi.org\/10.1093\/hropen\/hoag081","relation":{},"ISSN":["2399-3529"],"issn-type":[{"value":"2399-3529","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"hoag081"}}